The Clinical Study of Apatinib for Patients With Advanced Non-squamous Head and Neck Cancer
Latest Information Update: 07 Dec 2021
At a glance
- Drugs Rivoceranib (Primary)
- Indications Adenocarcinoma; Head and neck cancer
- Focus Therapeutic Use
- 12 Sep 2017 Results (n=10) presented at the 42nd European Society for Medical Oncology Congress
- 14 Dec 2016 New trial record